lungcancersymptomsx.com
Capmatinib for Lung Cancer Granted Breakthrough Therapy Designation
Officials with the FDA have granted breakthrough therapy designation to Norvatis' capmatinib therapy as an initial treatment for metastatic non-small cell lung cancer (NSCLC). Click to Read more.